tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ROIV Stock Latest News

Promising Potential of Roivant Sciences: Buy Rating for FcRn Inhibitor Advancements
RatingsPromising Potential of Roivant Sciences: Buy Rating for FcRn Inhibitor Advancements
21d ago
ROIV
Roivant Sciences Engages Former Officer for Advisory Role
PremiumCompany Announcements
Roivant Sciences Engages Former Officer for Advisory Role
21d ago
8K
ROIV
Roivant Sciences Announces Positive Results for Batoclimab Studies
PremiumCompany Announcements
Roivant Sciences Announces Positive Results for Batoclimab Studies
23d ago
8K
ROIV
Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG
PremiumThe Fly
Roivant says Immunovant announces results from Phase 3 study of batoclimab in MG
23d ago
IMVT
ROIV
Strategic Growth Potential in Roivant Sciences: Capitalizing on Graves’ Disease Market and FcRn Indications
PremiumRatings
Strategic Growth Potential in Roivant Sciences: Capitalizing on Graves’ Disease Market and FcRn Indications
30d ago
ROIV
Genevant, Arbutus initiate patent infringement actions against Moderna
PremiumThe FlyGenevant, Arbutus initiate patent infringement actions against Moderna
1M ago
ABUS
MRNA
Roivant Sciences announces replacement of Arbutus Biopharma board
Premium
The Fly
Roivant Sciences announces replacement of Arbutus Biopharma board
1M ago
ABUS
ROIV
Roivant Sciences Appoints New Chief Accounting Officer
Premium
Company Announcements
Roivant Sciences Appoints New Chief Accounting Officer
2M ago
8K
ROIV
Promising Future for Roivant Sciences: Strategic Investments and Pipeline Advancements Boost Buy Rating
PremiumRatings
Promising Future for Roivant Sciences: Strategic Investments and Pipeline Advancements Boost Buy Rating
2M ago
ROIV
3 Best Stocks to Buy Now, 2/11/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 2/11/2025, According to Top Analysts
2M ago
ALAB
INDI
Roivant Sciences: Strategic Advancements and Growth Prospects Underpin Buy Rating
PremiumRatings
Roivant Sciences: Strategic Advancements and Growth Prospects Underpin Buy Rating
2M ago
ROIV
Roivant Sciences price target lowered to $12 from $13 at BofA
PremiumThe Fly
Roivant Sciences price target lowered to $12 from $13 at BofA
2M ago
IMVT
ROIV
Roivant Sciences: Earnings Reveal Strategic Clinical Advances
PremiumCompany AnnouncementsRoivant Sciences: Earnings Reveal Strategic Clinical Advances
2M ago
ROIV
Roivant Sciences: Strong Earnings Call Amid Challenges
Premium
Company Announcements
Roivant Sciences: Strong Earnings Call Amid Challenges
2M ago
ROIV
Optimistic Outlook on Roivant Sciences: Strategic Pipeline Advancements and Growth Potential
Premium
Ratings
Optimistic Outlook on Roivant Sciences: Strategic Pipeline Advancements and Growth Potential
2M ago
ROIV
Roivant Sciences reports consolidated cash of $5.2B as of December 31
PremiumThe Fly
Roivant Sciences reports consolidated cash of $5.2B as of December 31
2M ago
ROIV
Roivant Sciences reports Q3 EPS (22c), consensus (24c)
PremiumThe Fly
Roivant Sciences reports Q3 EPS (22c), consensus (24c)
2M ago
ROIV
Roivant Sciences announces major upcoming milestones
PremiumThe Fly
Roivant Sciences announces major upcoming milestones
2M ago
ROIV
Is ROIV a Buy, Before Earnings?
PremiumPre-Earnings
Is ROIV a Buy, Before Earnings?
2M ago
ROIV
Zest Health announces $13M in seed funding
PremiumThe FlyZest Health announces $13M in seed funding
2M ago
ROIV
Vivek Ramaswamy’s Net Worth – The Youngest Billionaire Republican Presidential Candidate
Premium
Market News
Vivek Ramaswamy’s Net Worth – The Youngest Billionaire Republican Presidential Candidate
2M ago
RUM
TAK
Insider Trading: Immunovant’s (IMVT) Major Investor Boosts Stake by $337M
Premium
Market News
Insider Trading: Immunovant’s (IMVT) Major Investor Boosts Stake by $337M
3M ago
IMVT
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >